Status:
UNKNOWN
Working on Wellness (WOW) Intervention
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
VU University of Amsterdam
Conditions:
Physical Activity
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The main aim of this study is to measure the effectiveness of a worksite health promotion programme on improving physical activity behaviour and associated biological risk factors for cardiovascular d...
Detailed Description
Study Design: "Working on Wellness - WOW" is a randomised controlled trial in South African worksites with a 12 month follow-up. Randomisation will take place at the company level, where participatin...
Eligibility Criteria
Inclusion
- Employees identified to be at 'increased' or 'high' risk for CVD are eligible to take part in the research study. Risk status will be determined by using the (Euro) SCORE 12, together with their habitual physical activity levels, and Body Mass Index. SCORE incorporates age, total cholesterol, blood pressure and smoking status. This score ranks individuals according to their level of risk, ranging from very low to very high 10-year risk of fatal CVD (Appendix 1). Those with a risk of 5% or higher will be considered eligible.
- Independent of the risk score, employees who are inactive (i.e., who do not comply with at least 30 minutes of moderate to vigorous activity on at least 5 days per week), or who smoke, and employees who are overweight (i.e., Body Mass Index ≥ 25 kg/m2) also will be eligible to take part in the study. Other inclusion criteria include being older than 18 years and having a contract with employer until end of 12-month measurement period
Exclusion
- Employees will be excluded for the following reasons: pregnancy, diagnosis or treatment of cancer, any other disorder that makes physical activity impossible. Contract workers whose employ with the company will end before the 12 month follow up measurement, will also be excluded from the study.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT01494207
Start Date
November 1 2009
End Date
June 1 2012
Last Update
February 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cape Town
Cape Town, South Africa, 7725